Komori
M&A and Subsidiary Changes7575Japan Lifeline Co.,Ltd.Trading & Wholesale

Notice Concerning a Change in Specified Subsidiary Status Following a Capital Increase in a U.S. Subsidiary

Japan Lifeline Co.,Ltd. will make an additional investment of USD 10 million in its wholly owned U.S. subsidiary, JLL Med USA Inc., increasing its capital from USD 0.4 million to USD 10.4 million. As a result, JLL Med USA Inc. will become a specified subsidiary of Japan Lifeline Co.,Ltd.

Worth reading
41Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
10000
Thousand US dollars
Wording
Definitive
How definitive the wording is.

No category-specific facts could be extracted from this document.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The purpose is to strengthen JLL Med USA's financial base so that it can pursue business opportunities flexibly in the U.S. market. JLL Med USA aims to establish development and sales capabilities that address local medical needs and contribute to increasing the overall corporate value of the Group through the growth of its U.S. business.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning a Change in Specified Subsidiary Status Following a Capital Increase in a U.S. Subsidiary | Japan Lifeline Co.,Ltd. (7575) timely disclosure | Komori